ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$BCRX:NASDAQ · BIOCRYST PHARMACEUTICALS INC

Sector: health

Conviction from: NASDAQ

52-week range: 6.2311.22

Rare-disease drug developer (hereditary angioedema)

4 tracked filer(s) hold this · 0 opened, 3 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 61 — mean of 4 scored holder(s) · buyers (new/add) avg 61. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Louis Bacon / Moore52Added +20%1,021,869$8,512,1690.2%
Steve Cohen / Point7275Added +63%426,306$3,551,1290.0%
Bridgewater55Added +74%854,235$7,115,7780.0%
Paul Tudor Jones / Tudor61Trimmed -5%269,760$2,247,1010.0%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

1 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-07-10Gilbert Cisneros CA31BUY$1,001 - $15,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.